MedApp Statistics
Total Valuation
MedApp has a market cap or net worth of PLN 37.52 million. The enterprise value is 41.94 million.
Market Cap | 37.52M |
Enterprise Value | 41.94M |
Important Dates
The last earnings date was Monday, May 12, 2025.
Earnings Date | May 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
MedApp has 250.13 million shares outstanding.
Current Share Class | 250.13M |
Shares Outstanding | 250.13M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 120.53M |
Valuation Ratios
The trailing PE ratio is 146.63.
PE Ratio | 146.63 |
Forward PE | n/a |
PS Ratio | 4.94 |
PB Ratio | 1.32 |
P/TBV Ratio | n/a |
P/FCF Ratio | 183.02 |
P/OCF Ratio | 98.74 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.40, with an EV/FCF ratio of 204.58.
EV / Earnings | 163.83 |
EV / Sales | 5.52 |
EV / EBITDA | 9.40 |
EV / EBIT | 90.58 |
EV / FCF | 204.58 |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.07.
Current Ratio | 1.05 |
Quick Ratio | 0.36 |
Debt / Equity | 0.07 |
Debt / EBITDA | 0.46 |
Debt / FCF | 9.96 |
Interest Coverage | 3.86 |
Financial Efficiency
Return on equity (ROE) is 1.17% and return on invested capital (ROIC) is 0.95%.
Return on Equity (ROE) | 1.17% |
Return on Assets (ROA) | 0.75% |
Return on Invested Capital (ROIC) | 0.95% |
Return on Capital Employed (ROCE) | 1.57% |
Revenue Per Employee | 542,786 |
Profits Per Employee | 18,286 |
Employee Count | 16 |
Asset Turnover | 0.20 |
Inventory Turnover | 0.69 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.89% in the last 52 weeks. The beta is 1.04, so MedApp's price volatility has been similar to the market average.
Beta (5Y) | 1.04 |
52-Week Price Change | -53.89% |
50-Day Moving Average | 0.16 |
200-Day Moving Average | 0.18 |
Relative Strength Index (RSI) | 45.75 |
Average Volume (20 Days) | 19,231 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedApp had revenue of PLN 7.60 million and earned 256,000 in profits. Earnings per share was 0.00.
Revenue | 7.60M |
Gross Profit | 2.65M |
Operating Income | 463,000 |
Pretax Income | 349,000 |
Net Income | 256,000 |
EBITDA | 4.46M |
EBIT | 463,000 |
Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 409,000 in cash and 2.04 million in debt, giving a net cash position of -1.63 million or -0.01 per share.
Cash & Cash Equivalents | 409,000 |
Total Debt | 2.04M |
Net Cash | -1.63M |
Net Cash Per Share | -0.01 |
Equity (Book Value) | 28.38M |
Book Value Per Share | 0.10 |
Working Capital | 577,000 |
Cash Flow
In the last 12 months, operating cash flow was 380,000 and capital expenditures -175,000, giving a free cash flow of 205,000.
Operating Cash Flow | 380,000 |
Capital Expenditures | -175,000 |
Free Cash Flow | 205,000 |
FCF Per Share | 0.00 |
Margins
Gross margin is 34.81%, with operating and profit margins of 6.09% and 3.37%.
Gross Margin | 34.81% |
Operating Margin | 6.09% |
Pretax Margin | 4.59% |
Profit Margin | 3.37% |
EBITDA Margin | 58.73% |
EBIT Margin | 6.09% |
FCF Margin | 2.70% |
Dividends & Yields
MedApp does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 0.68% |
FCF Yield | 0.55% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
MedApp has an Altman Z-Score of 2.93. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.93 |
Piotroski F-Score | n/a |